References

Nutritional supplements and complementary therapies in polycystic ovary syndrome

10.1093/advances/nmab141 · 2022 · External reference

Gut microbiota in overweight and obesity: Crosstalk with adipose tissue

10.1038/s41575-023-00867-z · 2024 · External reference

Alpha-lipoic acid and glucose metabolism: A comprehensive update on biochemical and therapeutic features

10.3390/nu15010018 · 2022 · External reference

Metagenomic analysis identified microbiome alterations and pathological association between intestinal microbiota and polycystic ovary syndrome

10.1016/j.fertnstert.2020.01.027 · 2020 · External reference

The cellular and functional complexity of thermogenic fat

10.1038/s41580-021-00350-0 · 2021 · External reference

Interplay of gut microbiota in polycystic ovarian syndrome: Role of gut microbiota, mechanistic pathways and potential treatment strategies

10.3390/ph16020197 · 2023 · External reference

Akkermansia muciniphila and environmental enrichment reverse cognitive impairment associated with high-fat high-cholesterol consumption in rats

10.1080/19490976.2021.1880240 · 2021 · External reference

Reappraising the relationship between hyperinsulinemia and insulin resistance in PCOS

10.1530/joe-24-0269 · 2025 · External reference

Myricetin-induced brown adipose tissue activation prevents obesity and insulin resistance in db/db mice

10.1007/s00394-017-1433-z · 2018 · External reference

Brown adipose tissue development and metabolism

10.1007/164_2018_168 · 2019 · External reference

The promising effect of linagliptin and/or indole-3-carbinol on experimentally-induced polycystic ovarian syndrome

10.1016/j.cbi.2017.06.009 · 2017 · External reference

Gut microbial metabolites as multi-kingdom intermediates

10.1038/s41579-020-0438-4 · 2021 · External reference

Androgen reduces mitochondrial respiration in mouse brown adipocytes: A model for disordered energy balance in polycystic ovary syndrome

10.3390/ijms22010243 · 2020 · External reference

Characterization of brown adipose tissue (BAT) in polycystic ovary syndrome (PCOS) patients by Z-Spectral Imaging (ZSI)

10.1016/j.ejrad.2019.108777 · 2020 · External reference

Effects of androgen excess-related metabolic disturbances on granulosa cell function and follicular development

10.3389/fendo.2022.815968 · 2022 · External reference

Prebiotic properties of green and dark tea contribute to protective effects in chemical-induced colitis in mice: A fecal microbiota transplantation study

10.1021/acs.jafc.0c02336 · 2020 · External reference

xcms in peak form: Now anchoring a complete metabolomics data preprocessing and analysis software ecosystem

10.1021/acs.analchem.5c04338 · 2025 · External reference

Bacterial and metabolic phenotypes associated with inadequate response to ursodeoxycholic acid treatment in primary biliary cholangitis

10.1080/19490976.2023.2208501 · 2023 · External reference

Myricetin and M10, a myricetin-3-O-β-d-lactose sodium salt, modify composition of gut microbiota in mice with ulcerative colitis

10.1016/j.toxlet.2021.03.009 · 2021 · External reference

Gut microbiota-derived indole compounds attenuate metabolic dysfunction-associated steatotic liver disease by improving fat metabolism and inflammation

10.1080/19490976.2024.2307568 · 2024 · External reference

Insulin resistance and PCOS: Chicken or egg?

10.1007/s40618-020-01351-0 · 2021 · External reference

Rearing mice at 22°C programs increased capacity to respond to chronic exposure to cold but not high fat diet

10.1016/j.molmet.2023.101740 · 2023 · External reference

Brown adipose tissue activity is reduced in women with polycystic ovary syndrome

10.1530/eje-19-0505 · 2019 · External reference

Dimethyl itaconate ameliorates cognitive impairment induced by a high-fat diet via the gut-brain axis in mice

10.1186/s40168-023-01471-8 · 2023 · External reference

Gut microbiota-bile acid-interleukin-22 axis orchestrates polycystic ovary syndrome

10.1038/s41591-019-0509-0 · 2019 · External reference

Natural alkaloid bouchardatine ameliorates metabolic disorders in high-fat diet-fed mice by stimulating the sirtuin 1/liver kinase B-1/AMPK axis

10.1111/bph.13855 · 2017 · External reference

Follicle stimulating hormone (LH: FSH) ratio in polycystic ovary syndrome (PCOS) - obese vs. non- obese women

10.5455/medarh.2020.74.289-293 · 2020 · External reference

Identification of phenol- and p-cresol-producing intestinal bacteria by using media supplemented with tyrosine and its metabolites

10.1093/femsec/fiy125 · 2018 · External reference

Intestinal microbiota and metabolic diseases: Pharmacological implications

10.1016/j.tips.2015.11.010 · 2016 · External reference

Desulfovibrio in the gut: The enemy within?

10.3390/microorganisms11071772 · 2023 · External reference

Myricetin: A review of the most recent research

10.1016/j.biopha.2020.111017 · 2021 · External reference

Taxonomic identification of bile salt hydrolase-encoding lactobacilli: Modulation of the enterohepatic bile acid profile

10.1002/imt2.128 · 2023 · External reference

Myricetin supplementation decreases hepatic lipid synthesis and inflammation by modulating gut microbiota

10.1016/j.celrep.2021.109641 · 2021 · External reference

Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome

10.1210/clinem/dgad463 · 2023 · External reference

Exposure to a healthy gut microbiome protects against reproductive and metabolic dysregulation in a PCOS mouse model

10.1210/en.2019-00050 · 2019 · External reference

Dysbiosis of gut microbiota (DOGMA) – a novel theory for the development of Polycystic Ovarian Syndrome

10.1016/j.mehy.2012.04.016 · 2012 · External reference

Hyperandrogenemia and insulin resistance: The chief culprit of polycystic ovary syndrome

10.1016/j.lfs.2019.116940 · 2019 · External reference

Exploring the efficacy of Wenshentiaojing decoction in PCOS: Network pharmacology and mouse model insights

10.1016/j.bioorg.2024.108089 · 2025 · External reference

The sympathetic innervation of adipose tissues: Regulation, functions, and plasticity

10.1002/cphy.c220030 · 2023 · External reference

N-acetyl-L-leucine protects MPTP-treated Parkinson’s disease mouse models by suppressing Desulfobacterota via the gut-brain axis

10.1016/j.brainresbull.2023.110729 · 2023 · External reference

Brown adipose tissue activation by cold treatment ameliorates polycystic ovary syndrome in rat

10.3389/fendo.2021.744628 · 2021 · External reference

Gut microbiome in PCOS associates to serum metabolomics: A cross-sectional study

10.1038/s41598-022-25041-4 · 2022 · External reference

Brown adipose tissue transplantation ameliorates polycystic ovary syndrome

10.1073/pnas.1523236113 · 2016 · External reference

Methyl-3-indolylacetate inhibits cancer cell invasion by targeting the MEK1/2-ERK1/2 signaling pathway

10.1158/1535-7163.mct-06-0240 · 2006 · External reference

Brown adipose tissue transplantation ameliorates diabetic nephropathy through the miR-30b pathway by targeting Runx1

10.1016/j.metabol.2021.154916 · 2021 · External reference

Polycystic ovary syndrome: A metabolic disorder with therapeutic opportunities

10.1016/j.cmet.2025.08.002 · 2025 · External reference

Probiotic Clostridium butyricum ameliorates cognitive impairment in obesity via the microbiota-gut-brain axis

10.1016/j.bbi.2023.11.016 · 2024 · External reference

Myricetin ameliorates polycystic ovary syndrome in mice by brown adipose tissue activation

10.1530/rep-24-0034 · 2024 · External reference